---
schema_version: "secwatch.filing_event.v1"
accession: "0000019584-26-000010"
form_type: "8-K"
ticker: "CHE"
cik: "0000019584"
company_name: "CHEMED CORP"
filed_at: "2026-04-23T23:59:59+00:00"
generated_at: "2026-05-15T04:38:54.156725+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Chemed Q1 adjusted EPS $5.65; boosts 2026 guidance to $24.00-$24.75 on VITAS momentum

## Summary
- GAAP diluted EPS $4.84, down 0.4% YoY; adjusted EPS $5.65, up 0.4% YoY.
- Revenue $657.5M (+1.6%); VITAS revenue $420.0M (+3.1%); Roto-Rooter revenue $237.5M (-0.9%).
- VITAS ADC up 2.2% to 22,723; admissions up 6.9%; adjusted EBITDA ex-Medicare Cap $70.8M (+0.6%), margin 16.8%.
- Roto-Rooter adjusted EBITDA $53.5M (-9.6%), margin 22.5% (-218bps); acquired two franchises for $20.6M.
- FY 2026 adjusted EPS guidance raised to $24.00-$24.75 from $23.25-$24.25; repurchased 500k shares for $197.7M in Q1.

## SEC filing metadata
- accession: 0000019584-26-000010
- form_type: 8-K
- ticker: CHE
- cik: 0000019584
- company_name: CHEMED CORP
- filed_at: 2026-04-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/19584/000001958426000010/0000019584-26-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/19584/000001958426000010/che-20260423x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000019584-26-000010
- JSON: https://secwatch.observer/filing/0000019584-26-000010.json
- Plain text: https://secwatch.observer/filing/0000019584-26-000010.txt

## Key facts
- Earnings Releases
  CHEMED CORP reported first quarter ended March 31, 2026 results: revenue $657.5 million, EPS GAAP Diluted Earnings-per-Share (EPS) of $4.84.
  - Period: first quarter ended March 31, 2026
  - Revenue: $657.5 million
  - EPS: GAAP Diluted Earnings-per-Share (EPS) of $4.84
  - Result: reported results
  source text: quarter ended March 31, 2026, versus the comparable prior-year period.  Results for Quarter Ended March 31, 2026  Consolidated operating results: · Revenue increased 1.6% to $657.5 million · GAAP Diluted Earnings-per-Share (EPS) of $4.84, a decrease of 0.4% · Adjusted Diluted EPS of $5.65, an increase of 0.4%  VITAS segment operating results: · Net Patient Revenue
  evidence_url: https://www.sec.gov/Archives/edgar/data/19584/000001958426000010/0000019584-26-000010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.